Seelos Therapeutics (NASDAQ:SEEL)

Seelos Therapeutics (NASDAQ:SEEL)

Share Price
$ 1.89
-0.06 (-3.08 %)
Market Cap
$40.21 m
Proactive Investors - Run By Investors For Investors

Seelos Therapeutics

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company’s robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders,...

52-week High/Low: $13.950 / $1.330
Sector: Pharma & Biotech
Market Cap: $40.21 m
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Seelos Therapeutics

Seelos Therapeutics Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use